Synthesis and evaluation of novel 2-pyridone derivatives as inhibitors of phosphodiesterase3 (PDE3): a target for heart failure and platelet aggregation.
- DOI
- 10.1016/j.bmcl.2012.05.019
- Published
- 2012 Sep 15
- Container
- Bioorganic & medicinal chemistry letters
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bmcl.2012.05.019,
title = {Synthesis and evaluation of novel 2-pyridone derivatives as inhibitors of phosphodiesterase3 (PDE3): a target for heart failure and platelet aggregation.},
author = {Ravinder M and Mahendar B and Mattapally S and Hamsini KV and Reddy TN and Rohit C and Srinivas K and Banerjee SK and Rao VJ},
year = {2012},
journal = {Bioorganic \& medicinal chemistry letters},
doi = {10.1016/j.bmcl.2012.05.019},
url = {https://doi.org/10.1016/j.bmcl.2012.05.019}
}RIS
TY - JOUR TI - Synthesis and evaluation of novel 2-pyridone derivatives as inhibitors of phosphodiesterase3 (PDE3): a target for heart failure and platelet aggregation. AU - Ravinder M AU - Mahendar B AU - Mattapally S AU - Hamsini KV AU - Reddy TN AU - Rohit C AU - Srinivas K AU - Banerjee SK AU - Rao VJ PY - 2012 JO - Bioorganic & medicinal chemistry letters DO - 10.1016/j.bmcl.2012.05.019 UR - https://doi.org/10.1016/j.bmcl.2012.05.019 ER -
APA
M, R., B, M., S, M., KV, H., TN, R., C, R., K, S., SK, B., & VJ, R. (2012). Synthesis and evaluation of novel 2-pyridone derivatives as inhibitors of phosphodiesterase3 (PDE3): a target for heart failure and platelet aggregation.. Bioorganic & medicinal chemistry letters. https://doi.org/10.1016/j.bmcl.2012.05.019
Source records
- pubmed · retrieved 2026-09-25T15:31:53.698Z